Vault-13

KVP Capital Advisors, LP

SAN FRANCISCO, CA · CIK 1858198 · 13F filing filed 2026-08-13

SEC-registered investment adviser since 2026 · limited partnership

As an employer

$136.2m reported value +1.7% vs Q1 2026
35positions
57.4%in top 10
6 new 2 added 2 reduced 3 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 42,900 $14.4m10.54% 10.54% UnchangedShares held: Q3 2025 —, Q4 2025 42.9k, Q1 2026 42.9k, Q2 2026 42.9k
2 AADI BIOSCIENCE INC COM WHWK WHWK 2,165,997 $9.9m7.28% 7.28% UnchangedShares held: Q3 2025 —, Q4 2025 2.2m, Q1 2026 2.2m, Q2 2026 2.2m
3 ERASCA INC COM ERAS ERAS 455,000 $8.3m6.12% 6.12% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 340.0k, Q2 2026 455.0k +115.0k +115,000 33.8%
4 TREVI THERAPEUTICS INC COM TRVI TRVI 414,000 $7.7m5.67% 5.67% UnchangedShares held: Q3 2025 —, Q4 2025 414.0k, Q1 2026 414.0k, Q2 2026 414.0k
5 SUTRO BIOPHARMA INC COM SHS STRO STRO 226,575 $7.5m5.52% 5.52% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 226.6k, Q2 2026 226.6k
6 TANGO THERAPEUTICS INC COM TNGX TNGX 230,264 $7.2m5.28% 5.28% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 230.3k, Q2 2026 230.3k
7 MBX BIOSCIENCES INC COM MBX MBX 121,524 $6.7m4.92% 4.92% UnchangedShares held: Q3 2025 —, Q4 2025 121.5k, Q1 2026 121.5k, Q2 2026 121.5k
8 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 53,000 $6.5m4.77% 4.77% UnchangedShares held: Q3 2025 —, Q4 2025 53.0k, Q1 2026 53.0k, Q2 2026 53.0k
9 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 133,000 $5.4m3.97% 3.97% UnchangedShares held: Q3 2025 —, Q4 2025 133.0k, Q1 2026 133.0k, Q2 2026 133.0k
10 TANDEM DIABETES CARE INC COM NEW TNDM TNDM 301,000 $4.5m3.33% 3.33% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 301.0k
11 DISC MEDICINE INC COM IRON IRON 58,250 $4.3m3.13% 3.13% UnchangedShares held: Q3 2025 —, Q4 2025 58.2k, Q1 2026 58.2k, Q2 2026 58.2k
12 SAVARA INC COM SVRA SVRA 605,280 $3.7m2.74% 2.74% UnchangedShares held: Q3 2025 —, Q4 2025 605.3k, Q1 2026 605.3k, Q2 2026 605.3k
13 ARRIVENT BIOPHARMA INC COM AVBP AVBP 102,000 $3.5m2.60% 2.60% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 102.0k
14 INSMED INC COM PAR $.01 INSM INSM 28,497 $3.0m2.23% 2.23% UnchangedShares held: Q3 2025 —, Q4 2025 28.5k, Q1 2026 28.5k, Q2 2026 28.5k
15 ACHIEVE LIFE SCIENCES INC COM ACHV ACHV 462,355 $3.0m2.22% 2.22% UnchangedShares held: Q3 2025 —, Q4 2025 462.4k, Q1 2026 462.4k, Q2 2026 462.4k
16 IDEAYA BIOSCIENCES INC COM IDYA IDYA 79,700 $3.0m2.18% 2.18% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 79.7k, Q2 2026 79.7k
17 OCULAR THERAPEUTIX INC COM OCUL OCUL 300,000 $2.9m2.16% 2.16% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 300.0k, Q2 2026 300.0k
18 AXSOME THERAPEUTICS INC COM AXSM AXSM 12,000 $2.9m2.16% 2.16% ReducedShares held: Q3 2025 —, Q4 2025 36.2k, Q1 2026 36.2k, Q2 2026 12.0k -24.2k -24,200 -66.8%
19 DESIGN THERAPEUTICS INC COM DSGN DSGN 185,000 $2.7m1.96% 1.96% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 185.0k
20 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 4,750 $2.6m1.89% 1.89% UnchangedShares held: Q3 2025 —, Q4 2025 4.8k, Q1 2026 4.8k, Q2 2026 4.8k
21 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 45,000 $2.5m1.82% 1.82% UnchangedShares held: Q3 2025 —, Q4 2025 45.0k, Q1 2026 45.0k, Q2 2026 45.0k
22 IMMIX BIOPHARMA INC COM IMMX IMMX 230,423 $2.4m1.74% 1.74% UnchangedShares held: Q3 2025 —, Q4 2025 230.4k, Q1 2026 230.4k, Q2 2026 230.4k
23 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 125,000 $2.3m1.69% 1.69% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 125.0k, Q2 2026 125.0k
24 MINERALYS THERAPEUTICS INC COM MLYS MLYS 84,168 $2.3m1.67% 1.67% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 84.2k
25 BRIGHT MINDS BIOSCIENCES INC COM NEW DRUG DRUG 31,813 $2.2m1.64% 1.64% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 31.8k, Q2 2026 31.8k
26 TRAVERE THERAPEUTICS INC COM TVTX TVTX 39,000 $2.2m1.63% 1.63% ReducedShares held: Q3 2025 —, Q4 2025 91.0k, Q1 2026 91.0k, Q2 2026 39.0k -52.0k -52,000 -57.1%
27 ZURA BIO LTD CLASS A ORD SHS ZURA ZURA 373,128 $2.2m1.62% 1.62% UnchangedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 373.1k, Q2 2026 373.1k
28 ARTIVA BIOTHERAPEUTICS INC COM ARTV ARTV 200,000 $1.9m1.42% 1.42% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 200.0k
29 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 26,900 $1.9m1.38% 1.38% UnchangedShares held: Q3 2025 —, Q4 2025 26.9k, Q1 2026 26.9k, Q2 2026 26.9k
30 COMPASS THERAPEUTICS INC COM CMPX CMPX 771,000 $1.7m1.24% 1.24% AddedShares held: Q3 2025 —, Q4 2025 0, Q1 2026 500.0k, Q2 2026 771.0k +271.0k +271,000 54.2%
31 CABALETTA BIO INC COM CABA CABA 505,431 $1.6m1.15% 1.15% UnchangedShares held: Q3 2025 —, Q4 2025 505.4k, Q1 2026 505.4k, Q2 2026 505.4k
32 VERA THERAPEUTICS INC CL A VERA VERA 32,700 $1.4m1.03% 1.03% UnchangedShares held: Q3 2025 —, Q4 2025 32.7k, Q1 2026 32.7k, Q2 2026 32.7k
33 EVOLUS INC COM EOLS EOLS 150,000 $1.0m0.76% 0.76% NewShares held: Q3 2025 —, Q4 2025 0, Q1 2026 0, Q2 2026 150.0k
34 CELCUITY INC COM CELC CELC 4,000 $418.5k0.31% 0.31% UnchangedShares held: Q3 2025 —, Q4 2025 4.0k, Q1 2026 4.0k, Q2 2026 4.0k
35 VYNE THERAPEUTICS INC COM COM 500,551 $325.7k0.24% 0.24% UnchangedShares held: Q3 2025 —, Q4 2025 500.6k, Q1 2026 500.6k, Q2 2026 500.6k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
TERNS PHARMACEUTICALS INC 440,000 $23.2m440.0k shares
REVOLUTION MEDICINES INC RVMD RVMD 40,200 $3.9m40.2k shares
SOLENO THERAPEUTICS INC SLNO SLNO 59,700 $2.0m59.7k shares